Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
Moine E, Dimier-Poisson I, Enguehard-Gueiffier C, Logé C, Pénichon M, Moiré N, Delehouzé C, Foll-Josselin B, Ruchaud S, Bach S, Gueiffier A, Debierre-Grockiego F, Denevault-Sabourin C. Moine E, et al. Among authors: penichon m. Eur J Med Chem. 2015 Nov 13;105:80-105. doi: 10.1016/j.ejmech.2015.10.004. Epub 2015 Oct 9. Eur J Med Chem. 2015. PMID: 26479029
Bioinspired imidazo[1,2-a:4,5-c']dipyridines with dual antiproliferative and anti-migrative properties in human cancer cells: The SAR investigation.
Alzain AA, Brisson L, Delaye PO, Pénichon M, Chadet S, Besson P, Chevalier S, Allouchi H, Mohamed MA, Roger S, Enguehard-Gueiffier C. Alzain AA, et al. Among authors: penichon m. Eur J Med Chem. 2021 Jun 5;218:113258. doi: 10.1016/j.ejmech.2021.113258. Epub 2021 Feb 13. Eur J Med Chem. 2021. PMID: 33813152
Emerging therapeutics: The imidazo[1,2-b]pyridazine scaffold as a novel drug candidate for eumycetoma, a neglected tropical disease.
Elkheir LYM, Delaye PO, Penichon M, Eadie K, Mohamed MA, Besson P, Chesnay A, Desoubeaux G, Roger S, van de Sande WWJ, Fahal AH, Enguehard-Gueiffier C. Elkheir LYM, et al. Among authors: penichon m. Eur J Med Chem. 2024 Nov 5;277:116720. doi: 10.1016/j.ejmech.2024.116720. Epub 2024 Jul 26. Eur J Med Chem. 2024. PMID: 39142148 Free article.
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.
Bezin J, Gouverneur A, Pénichon M, Mathieu C, Garrel R, Hillaire-Buys D, Pariente A, Faillie JL. Bezin J, et al. Among authors: penichon m. Diabetes Care. 2023 Feb 1;46(2):384-390. doi: 10.2337/dc22-1148. Diabetes Care. 2023. PMID: 36356111
Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS).
Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C. Thurin NH, et al. Among authors: penichon m. Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):320-333. doi: 10.1002/pds.5161. Epub 2020 Nov 19. Pharmacoepidemiol Drug Saf. 2021. PMID: 33099844
12 results